1-ethyl-2-benzimidazolinone has been researched along with Carcinoma, Squamous Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, Y; Lee, EL; Okada, Y; Shimizu, T | 1 |
1 other study(ies) available for 1-ethyl-2-benzimidazolinone and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
IK1 channel activity contributes to cisplatin sensitivity of human epidermoid cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Benzimidazoles; Calcium; Carcinoma, Squamous Cell; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Size; Cell Survival; Cisplatin; Clotrimazole; Drug Resistance, Neoplasm; Humans; Hypotonic Solutions; Immunochemistry; Intermediate-Conductance Calcium-Activated Potassium Channels; Membrane Potentials; Patch-Clamp Techniques; Potassium Channel Blockers; Pyrazoles; Reverse Transcriptase Polymerase Chain Reaction | 2008 |